Laser Speckle Imaging System (RFLSI CZW)
Probe, Blood-Flow, Extravascular. 510(k) K233076, from Rwd Life Science Co., Ltd. (Shenzhen, CN). Product code DPT, class 2.
As of Nov 18, 2026, K233076 is an FDA 510(k) held by Rwd Life Science Co., Ltd., substantially equivalent on May 28, 2024 after 245 days, with no recalls tied to it in FDA's recall database.
- Substantially equivalent: May 28, 2024
- Review time: 245 days
- Recalls: 0
Indications for Use
As the 510(k) summary states them, read from FDA's summary PDFThe Laser Speckle Imaging System (RFLSI CZW) is intended for blood flow measurements in the micro-circulation. This device is intended for clinical research use.
Predicate Devices
The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF- MOORFLPI-2 Full-Field Laser Perfusion ImagerK122943 · Moor Instruments, Ltd. · Jan 3, 2013
Record
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Sep 26, 2023
- Review panel
- Cardiovascular
- Regulation
- 21 CFR 870.2120
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files